Sagimet Net Interest Income from 2010 to 2025
| SGMT Stock | 5.96 0.10 1.65% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 8.9 M | Current Value 9.3 M | Quarterly Volatility 3.1 M |
Check Sagimet Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sagimet Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 9.3 M, Interest Income of 9.3 M or Depreciation And Amortization of 18.8 M, as well as many indicators such as Price To Sales Ratio of 39.45, Dividend Yield of 0.0 or PTB Ratio of 0.86. Sagimet financial statements analysis is a perfect complement when working with Sagimet Biosciences Valuation or Volatility modules.
Sagimet | Net Interest Income | Build AI portfolio with Sagimet Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sagimet Stock Analysis
When running Sagimet Biosciences' price analysis, check to measure Sagimet Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sagimet Biosciences is operating at the current time. Most of Sagimet Biosciences' value examination focuses on studying past and present price action to predict the probability of Sagimet Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sagimet Biosciences' price. Additionally, you may evaluate how the addition of Sagimet Biosciences to your portfolios can decrease your overall portfolio volatility.